NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

From NW's recent comments.

"Our long-term aim is also to help the company get into a position where it can attract the consistent funding it will need to successfully complete a Phase III clinical study and beyond. If the company is going to move into a sustainable position to attract a broader range of investors that, in turn, will give it a runway to complete its clinical trials, it needs to put these allegations to rest once and for all."

Considering these comments in conjunction with the Ondra requirement/initiative, what are everyone's thoughts concerning NW's desire or ability to continue financing NWBO? Also, curious about his Phase III comments in light of the speculation that enrollment is complete, AA is underway, and that HE reimbursement negotiations are close at hand (wouldn't revenue potential be on the near horizon?)